Selectable marker genes

Details for Australian Patent Application No. 2001273906 (hide)

Owner Novartis AG

Inventors Veres, Gabor; Pippig, Susanne Dagmar

Agent Davies Collison Cave

Pub. Number AU-B-2001273906

PCT Pub. Number WO01/72834

Priority 09539248 30.03.00 US

Filing date 28 March 2001

Wipo publication date 8 October 2001

Acceptance publication date 4 August 2005

International Classifications

C07K 014/705 Peptides having more than 20 amino acids

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 033/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

Event Publications

4 August 2005 Application Accepted

  Published as AU-B-2001273906

1 December 2005 Standard Patent Sealed

23 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001273907-A method of producing IgG

2001273905